Tauroursodeoxycholate—bile acid with chaperoning activity: molecular and cellular effects and therapeutic perspectives

M Kusaczuk - Cells, 2019 - mdpi.com
Tauroursodeoxycholic acid (TUDCA) is a naturally occurring hydrophilic bile acid that has
been used for centuries in Chinese medicine. Chemically, TUDCA is a taurine conjugate of …

Update on FXR biology: promising therapeutic target?

CY Han - International journal of molecular sciences, 2018 - mdpi.com
Farnesoid X receptor (FXR), a metabolic nuclear receptor, plays critical roles in the
maintenance of systemic energy homeostasis and the integrity of many organs, including …

Reversal of the renal hyperglycemic memory in diabetic kidney disease by targeting sustained tubular p21 expression

MM Al-Dabet, K Shahzad, A Elwakiel, A Sulaj… - Nature …, 2022 - nature.com
A major obstacle in diabetes is the metabolic or hyperglycemic memory, which lacks specific
therapies. Here we show that glucose-mediated changes in gene expression largely persist …

Neutrophil extracellular traps promote NLRP3 inflammasome activation and glomerular endothelial dysfunction in diabetic kidney disease

A Gupta, K Singh, S Fatima, S Ambreen… - Nutrients, 2022 - mdpi.com
Diabetes mellitus is a metabolic disease largely due to lifestyle and nutritional imbalance,
resulting in insulin resistance, hyperglycemia and vascular complications. Diabetic kidney …

The role of the farnesoid X receptor in kidney health and disease: a potential therapeutic target in kidney diseases

DH Kim, JS Park, HI Choi, CS Kim, EH Bae… - … & molecular medicine, 2023 - nature.com
The prevalence of kidney diseases has been increasing worldwide due to the aging
population and has results in an increased socioeconomic burden as well as increased …

Recent advances in the medicinal chemistry of farnesoid X receptor

Y Fang, L Hegazy, BN Finck… - Journal of Medicinal …, 2021 - ACS Publications
Farnesoid X receptor (FXR) is an important regulator of bile acid, lipid, amino acid, and
glucose homeostasis, hepatic inflammation, regeneration, and fibrosis. FXR has been …

Roles of gut microbial metabolites in diabetic kidney disease

Q Fang, N Liu, B Zheng, F Guo, X Zeng… - Frontiers in …, 2021 - frontiersin.org
Diabetes is a highly prevalent metabolic disease that has emerged as a global challenge
due to its increasing prevalence and lack of sustainable treatment. Diabetic kidney disease …

Targeting gut microbial bile salt hydrolase (BSH) by diet supplements: new insights into dietary modulation of human health

Y Yang, C Wu - Food & Function, 2022 - pubs.rsc.org
The gut microbiome is increasingly recognized as a vital organ that participates in nutrient
acquisition, energy regulation and maintenance of human health. Targeted manipulation of …

The pathophysiological function of non-gastrointestinal farnesoid X receptor

N Yan, T Yan, Y Xia, H Hao, G Wang… - Pharmacology & …, 2021 - Elsevier
Farnesoid X receptor (FXR) influences bile acid homeostasis and the progression of various
diseases. While the roles of hepatic and intestinal FXR in enterohepatic transport of bile …

Tissue factor binds to and inhibits interferon-α receptor 1 signaling

J Manoharan, R Rana, G Kuenze, D Gupta, A Elwakiel… - Immunity, 2024 - cell.com
Tissue factor (TF), which is a member of the cytokine receptor family, promotes coagulation
and coagulation-dependent inflammation. TF also exerts protective effects through unknown …